Huanfa Yi Selected Research

Arginase

1/2020

Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huanfa Yi Research Topics

Disease

13	Neoplasms (Cancer) 05/2020 - 06/2009
3	Neoplasm Metastasis (Metastasis) 04/2013 - 11/2011
3	Melanoma (Melanoma, Malignant) 04/2013 - 04/2011
2	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 04/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2020
2	Rheumatoid Arthritis 01/2020 - 01/2020
2	Carcinogenesis 01/2020 - 01/2019
2	Experimental Melanoma 04/2013 - 09/2011
2	Prostatic Neoplasms (Prostate Cancer) 11/2012 - 03/2011
2	Infections 04/2012 - 06/2009
2	Atherosclerosis 04/2012 - 06/2009
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Multiple Sclerosis 12/2020
1	Necrosis 05/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma of Lung 01/2020
1	Osteoporosis 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Dacryocystitis (Dacryoadenitis) 01/2020
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2020
1	Colitis 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020
1	Glioma (Gliomas) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2019
1	Uveitis 11/2016
1	Hepatitis 01/2013
1	Disease Progression 11/2012
1	Pathologic Processes 04/2012
1	Shock 04/2012
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Vesicular Stomatitis 04/2011
1	Virus Diseases (Viral Diseases) 04/2011

Drug/Important Bio-Agent (IBA)

6	Scavenger Receptors (Scavenger Receptor)IBA 01/2020 - 06/2009
5	AntigensIBA 04/2013 - 03/2011
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
4	VaccinesIBA 01/2018 - 09/2011
2	Biological ProductsIBA 05/2020 - 01/2020
2	Estrogens (Estrogen)FDA Link 01/2020 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 01/2020
2	Interleukin-17 (Interleukin 17)IBA 01/2020 - 11/2016
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2012 - 09/2011
1	SmokeIBA 01/2022
1	Pharmaceutical PreparationsIBA 12/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2020
1	Methylprednisolone FDA LinkGeneric 12/2020
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 12/2020
1	Anti-Allergic Agents (Antiallergic Agents)IBA 12/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2020
1	QuercetinIBA 05/2020
1	CateninsIBA 01/2020
1	ArginaseIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Circular RNAIBA 01/2020
1	curculigosideIBA 01/2020
1	NitrogenIBA 01/2020
1	16S Ribosomal RNAIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	ChromatinIBA 01/2020
1	celastrol methyl esterIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2019
1	Interleukin-33IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2016
1	interstitial retinol-binding proteinIBA 11/2016
1	FlagellinIBA 04/2013
1	InterleukinsIBA 04/2013
1	glucose-regulated protein 170IBA 04/2013
1	Concanavalin AIBA 01/2013
1	Gemcitabine FDA Link 11/2012
1	CytokinesIBA 11/2012
1	CPG-oligonucleotideIBA 04/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2011
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	Antiviral Agents (Antivirals)IBA 04/2011
1	Toll-Like Receptor 3IBA 04/2011
1	H-Y AntigenIBA 03/2011
1	Interleukin-2 (IL2)IBA 03/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2009
1	AntibodiesIBA 04/2008

Therapy/Procedure

6	Immunotherapy 05/2020 - 03/2011
5	Therapeutics 05/2020 - 04/2013
1	Drug Therapy (Chemotherapy) 01/2020
1	Radiotherapy 11/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2011
1	Organ Transplantation 04/2008